US Patent 11433132 Polyomavirus neutralizing antibodies
Patent 11433132 was granted and assigned to Novartis on September, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Elisabetta Traggiai0
Johanna Abend0
John Michael Lindner0
Vanessa Cornacchione0
Edits on 3 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 22 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 7 Sep, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+183 characters)
US Patent 11433132 Polyomavirus neutralizing antibodies
Article
The present invention relates to anti-polyomavirus antibodies, antibody fragments, and their uses for the prevention and treatment of BK or JC virus infection and associated diseases.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11433132
Date of Patent
September 6, 2022
Patent Application Number
16768429
Date Filed
November 28, 2018
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11433132 Polyomavirus neutralizing antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
